Fig. 5.

Graph shows the per capita health expenditure and the relationship between the production of scientific literature on second-generation antipsychotic drugs, and per capita health expenditure and gross domestic expenditure on R&D in the world's ten most productive countries in biomedicine and health sciences, and Singapore.

Source: Data on total health expenditure per capita PPP USD from OECD 2009;(20) data on Japan and Australia from OECD 2008;(20) data on China and Singapore (in PPP International dollars) from WHO 2008.(21) Data on gross domestic expenditure on R&D from OECD 2010,(20) except for USA and Japan (data from OECD 2009),(20) China (data from OECD 2007),(20) and Singapore (data from Global Finance Magazine 2008; http://www.gfmag.com).

OECD: Organisation for Economic Co-operation and Development; PI: participation index; PPP: purchasing power parity; R&D: research and development; UK: United Kingdom; USA: United States of America; USD: United States dollars; WHO: World Health Organization